![](/img/cover-not-exists.png)
Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
Jacobson, J. M., Lalezari, J. P., Thompson, M. A., Fichtenbaum, C. J., Saag, M. S., Zingman, B. S., D'Ambrosio, P., Stambler, N., Rotshteyn, Y., Marozsan, A. J., Maddon, P. J., Morris, S. A., Olson, WVolume:
54
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00086-10
Date:
October, 2010
File:
PDF, 369 KB
english, 2010